ArticleJournal of anaesthesiology, clinical pharmacology

Response to: "Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis".

Leslie A Tive et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.